Skip to content

Clinical trials

Phase 3 Head and Neck Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 3 Clear all

176 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20014
20024
20032
20047
20059
200611
20076
20088
20094
20103
20115
20125
20134
20143
20159
20164
20176
20185
20195
202010
20212
20223
20231
20244
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Terminated26
Unknown status22
Recruiting16
Active, not recruiting11
Withdrawn8
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radiation Therapy Oncology Group14
Boehringer Ingelheim6
Alliance for Clinical Trials in Oncology5
Eastern Cooperative Oncology Group5
European Organisation for Research and Treatment of Cancer - EORTC5
GlaxoSmithKline4
Sanofi4
Groupe Oncologie Radiotherapie Tete et Cou3
Merck Sharp & Dohme LLC3
All India Institute of Medical Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms176
Squamous Cell Carcinoma of Head and Neck71
Neoplasms13
Carcinoma, Squamous Cell12
Radiation Injuries12
Stomatitis10
Oropharyngeal Neoplasms9
Mucositis8
Salivary Gland Neoplasms8
Tongue Neoplasms8

Trials

Showing 1 to 25 of 176. Each trial links to its page on Pharma Observatory.

76 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.